As receptor, FPR2 displays potent mucosal protection and promotes catabasis after acute lung injury (ALI) [50], providing a novel therapeutic target to develop an effective treatment against ALI progression. This evidence concerns the gene FPR2 and acute respiratory distress syndrome.